Authors
Loading...
Review reveals multi-target modulation by hybrid heteroaromatics in complex diseases, indicating opportunities to reduce side effects seen with single-target cancer therapies.
Abbot et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: